Hui Yi Shan
Program Director, Nephrology Fellowship Program
Director of Peritoneal Dialysis at DaVita Boyle Heights
Contact
Barnard College: Mary E. Allison Prize, 1999
Barnard College, Department of Biology: Spiera Family Prize, 1999
Barnard College: Helen R. Downes Prize, 1999
Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury Dig Dis Sci. 2016 12; 61(12):3609-3620. . View in PubMed
Successful management of intractable gross hematuria with vasopressin in polycystic kidney disease J Urol Ren Dis. 2016; J113. . View in PubMed
A method for distinguishing the intended margins for a melanoma from the tissue cones after surgical excision Int J Dermatol. 2011 Dec; 50(12):1560-3. . View in PubMed
Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis Am J Kidney Dis. 2008 Jun; 51(6):1029-32. . View in PubMed
Severe protracted fever following pneumococcal vaccine Am J Med Sci. 2006 Dec; 332(6):351-3. . View in PubMed
Dr. Shan earned her medical degree from New York University School of Medicine. She performed her residency at New York University Medical Center, followed by a Nephrology Fellowship at Beth Israel Deaconess Medical Center- Harvard Medical School.
Dr. Shan's clinic areas of expertise:
ADVANCED KIDNEY DISEASES CLINIC
Dr. Shan has broad experience in managing patients with advanced kidney disease. She previously served as a nephrology consultant at New York University Medical Center and Kaiser Permanente. Since 2015 she has been working USC.
CYSTIC AND INTERSTITIAL DISEASES CLINIC
Dr. Shan has broad experience in managing patients with advanced kidney diseases. Her care of patients with cystic diseases focuses on delaying progression of kidney disease and the appropriate transition to transplantation or renal replacement therapy.
GLOMERULOPATHY CLINIC
Dr. Shan has broad experience in the care of patients with glomerular kidney diseases. She is utilizing multicenter clinical research studies to advance patient care and knowledge in the area of glomerulopathies.